TopoTarget and Spectrum Pharmaceuticals (SPPI) In Deal To Commercialize Belinostat in North America and India
Tweet Send to a Friend
TopoTarget A/S and Spectrum Pharmaceuticals Inc. (Nasdaq: SPPI) announced an agreement to co-develop and commercialise belinostat, TopoTarget's lead anticancer drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
